$XALL should have a very good year in 2022. The latest news

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
434
$XALL should have a very good year in 2022. The latest news from the company showed us that they are moving forward with their program that helps young, high potential companies get the traction needed to succeed in a timely manner and start returning enhanced value.

Xalles Announces the First Companies to Participate in the Xalles Studio Accelerator Program

Four growth firms and startups join the Xalles Studio as its inaugural participants


WASHINGTON, D.C., Dec. 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing technology and financial services solutions, today announced the first four companies to participate in the Xalles Studio Accelerator Program. The program is available for early-stage technology companies looking to reach the next significant financial transaction event.

Xalles Studio is a business unit of Xalles Capital Inc., a wholly owned subsidiary of Xalles Holdings Inc., and the Xalles Studio business model includes creating a portfolio of minority ownership stakes in a variety of Fintech, InsurTech, EnergyTech, HealthTech and other technology companies. Through its accelerator program, Xalles Studio connects early-stage technology companies with essential resources needed to launch, grow, and succeed through mentorship, networking, capital access, business development, and shared services that can be delivered globally.

Xalles is announcing that Coatcha Limited in the UK, SpeechMed (Taylannas, Inc.) of Florida, FetchCoins, Inc. of Maryland, and Appy Perks Inc. of Nevada are now officially engaged with Xalles Studio. Appy Perks offers businesses a fun way to bring in new customers and improve retention by allowing local customers to "Spin for Perks" that are offered by your business. FetchCoins will be the premier platform for pet and brand engagement. Through an innovative mix of technology and computer science, users can connect with brands effortlessly and earn great rewards. SpeechMed helps to make medical information understandable for everyone at any time through the first healthcare app where users can read and listen to vital medical information in their own language. Coatcha is using a correspondent banking relationship model, to facilitate fast inexpensive payments while profiting from the foreign exchange transfers.

“These inaugural participants in our program each bring a strong vision and innovative thinking to each of their own marketplaces,” stated Bob Trevelyan, Managing Director of Xalles Studio. He continued, “Our program will work to bring each of these companies to the next significant financial event.”

Xalles Studio is open to receiving new inquiries and applications through info@Xalles.com.

About Xalles Holdings Inc. (OTC: XALL)

Xalles Holdings Inc. is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information visit: http://Xalles.com

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com

Investor Relations Contact:
info@xalles.com
http://www.xalles.com
202.595.1299 Office
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tech Job Market Surges: 86,000 Hires in August Boost

Updated Category News Views 2

Tech Job Growth Defies Corporate Layoffs Job markets in the tech world are hotter than a two-dollar pistol. Despite seeing some layoffs in tech firms, the demand for skilled tech workers is still booming. You got tech companies tightening the bolts, laying off around 14,700 folks, but here's the kicker: overall tech employment shot up with 86,000 new jobs in August....

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 1

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
AEVEX Faces $100K+ Losses in New Investor Lawsuit

Updated Category News Views 1

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Continue Reading
Rho Adds Credit Card Payments to Invoices

Updated Category News Views 2

Rho's New Game: Credit Card Payments on Invoices Ah, the wonderful world where your invoices can finally ride the plastic wave! Rho, that scrappy finance platform everyone's been chattering about, just rolled out a card payment feature. Yep, from credit cards to Google Pay, they’re letting businesses skip the usual financial hurdles and get their dough directly from...

Continue Reading
CRESYN Opens Model Residence: A Peek at City Living

Updated Category News Views 3

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 2

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyst Insights on Humana's Q3 Earnings Expectations

Updated Category News Views 198

Analyst Insights on Humana's Q3 Earnings Expectations As Humana prepares for its upcoming earnings report, analysts are closely examining the expected performance metrics. The consensus among Wall Street experts is that Humana (NYSE: HUM) will report earnings of approximately $3.48 per share. This figure marks a notable decline of 55.3% compared to the same quarter last...

Continue Reading
Mastering Price Breakouts: Avoid Common Trading Pitfalls

Updated Category News Views 277

Understanding Price Breakouts in Trading Price breakouts are captivating setups in the trading world. However, traders often find themselves misled when relying solely on price movements without considering essential indicators. The reality of the market is that many breakouts are merely illusions that can deceive traders unprepared for unexpected reversals. Recognizing...

Continue Reading
Maximize Earnings: Earning $500 Monthly with Pfizer Stock

Updated Category News Views 108

Unlocking Earnings Potential with Pfizer Pfizer Inc. (NYSE: PFE) has positioned itself uniquely in the healthcare sector, and as it approaches its third-quarter earnings announcement, many investors are contemplating the opportunities its stock presents. Analysts anticipate that Pfizer will report earnings around 64 cents per share, a decrease compared to $1.06 in the...

Continue Reading
Addressing Unfair Trade Practices in the Trailer Industry

Updated Category News Views 215

The Urgent Need for Trade Protection in the Trailer Industry Undoubtedly, the American trailer industry is at a critical juncture. Recent actions by the American Trailer Manufacturers Coalition highlight the pressing need for antidumping and countervailing duties as imports of van trailers from foreign countries like China, Canada, and Mexico flood the market at unfairly...

Continue Reading
Genius Group Marks Another Milestone with Recent Buyback

Updated Category News Views 145

Genius Group Executes Share Buyback to Boost Investor Value Genius Group Limited (NYSE: GNS), a pioneering entity in the AI-driven education sector, has made headlines with its recent buyback of one million shares, a strategic move undertaken to reinforce shareholder confidence and value. This transaction occurred against the backdrop of a well-defined plan, allowing the...

Continue Reading